课题基金 / 基金详情

Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024

Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024
华盛顿大学神经科学临床试验卓越网络 (NeuroNEXT) 临床研究网站 - RFA-NS-17-024
批准号:
10593625
负责人:
DAVID B CLIFFORD
金额:
$27.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2024-06-30

项目摘要

项目成果

DAVID B CLIFFORD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will continue the Washington University NeuroNEXT site contributing to the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) program. The overall goal of the program will contribute to the success in identifying and completing Phase 2 clinical trials that will speed translation of concepts to clinical practice for neurological conditions. The project will enhance the infrastructure for neuroscience related clinical trials at Washington University in St Louis (WUSTL) through supporting critical leadership personnel, support for the Neurological Clinical Research Unit (NCRU) and administrative infrastructure for multicenter clinical trials performance at WUSTL. The grant will provide key leadership assuring the efficient conduct of NeuroNEXT network clinical trials at WUSTL by funding a site PI and coordinator committed to assuring timely and accurate assessment of proposed concepts, organization and support of site protocol teams, and quality oversight for NeuroNEXT trials. The project also supports training for emerging investigators for participation in neurological clinical research through a program to support an outstanding younger investigator financially and through mentoring and formal training in theoretical and practical clinical trial practices, thus enriching the pool of investigators available for future investigations.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Nemesis of neglected neurosarcoidosis.
被忽视的神经结节病的克星。
DOI: 10.1002/acn3.247
发表时间: 2015
期刊: Annals of clinical and translational neurology
影响因子: 5.3
作者: [Clifford,DavidB]
通讯作者: Clifford,DavidB
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials.
为维多珠单抗临床试验开发的风险评估和最小化进行性多灶性白质脑病的计划。
DOI: 10.1007/s40264-018-0669-8
发表时间: 2018
期刊: Drug safety
影响因子: 4.2
作者: [Parikh,Asit, Stephens,Kristin, Major,Eugene, Fox,Irving, Milch,Catherine, Sankoh,Serap, Lev,MichaelH, Provenzale,JamesM, Shick,Jesse, Patti,Mark, McAuliffe,Megan, Berger,JosephR, Clifford,DavidB]
通讯作者: Clifford,DavidB
DOI: 10.1007/s13365-013-0165-y
发表时间: 2013-06
期刊: JOURNAL OF NEUROVIROLOGY
影响因子: 3.2
作者: [Solomon, Isaac H., Perrin, Richard J., Clifford, David B., Ances, Beau M.]
通讯作者: Ances, Beau M.
Washington University Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)- RFA-NS-17-024
  • 批准号:
    10163925
  • 项目类别:
  • 资助金额:
    $28.83万
  • 财政年份:
    2018
  • 负责人:
    DAVID B CLIFFORD
  • 依托单位:
Washington University Network of Excellence in Neuroscience Clinical Trials Site
  • 批准号:
    8337822
  • 项目类别:
  • 资助金额:
    $30.06万
  • 财政年份:
    2011
  • 负责人:
    DAVID B CLIFFORD
  • 依托单位:
Washington University Network of Excellence in Neuroscience Clinical Trials Site
  • 批准号:
    8533051
  • 项目类别:
  • 资助金额:
    $25.19万
  • 财政年份:
    2011
  • 负责人:
    DAVID B CLIFFORD
  • 依托单位:
Washington University Network of Excellence in Neuroscience Clinical Trials Site
  • 批准号:
    8721492
  • 项目类别:
  • 资助金额:
    $24.27万
  • 财政年份:
    2011
  • 负责人:
    DAVID B CLIFFORD
  • 依托单位:
海外基金